Ciprofloxacin And Dexamethasone Suspension/ Drops
Product Images NDC 70244-033

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ciprofloxacin And Dexamethasone (NDC 70244-033). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sentiss Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label (Ciprodex 7.5 mL Carton Label)

Ciprofloxacin and dexamethasone 0.3% and 0.1% otic suspension in a 7.5 mL package, labeled for auricular use only. The label includes active ingredient details, dosage instructions, storage conditions, and a warning to shake well before use. Distributed by Sentiss Pharmaceuticals LLC and made in Switzerland with an NDC of 70244-033-01.*

FDA Label Image

Container Label (Ciprodex 7.5 mL Container Label)

Label for Ciprofloxacin and dexamethasone suspension/drops for auricular use with strengths of 3 mg/mL and 1 mg/mL. The label shows the product is a human prescription drug provided by Sentiss Pharmaceuticals LLC and is packaged in a 7.5 mL bottle. The label includes dosage, usage instructions, and storage information.*

FDA Label Image

Cipro Structure (Spl Ciprofloxacin Structure)

Chemical structure of ciprofloxacin hydrochloride monohydrate, an active ingredient in Ciprofloxacin and dexamethasone otic suspension/drops. The structure shows a fluoroquinolone core with characteristic rings, a piperazine moiety, and associated chemical groups including a carboxylic acid, hydrochloride, and water of hydration.*

FDA Label Image

Dexa Structure (Spl Dexamethasone Structure)

Chemical structure of dexamethasone depicted in a molecular diagram highlighting its steroid framework with functional groups including hydroxyl and ketone moieties.*

FDA Label Image

Figure B (Spl Figure A)

An instructional illustration showing a person holding a small bottle of suspension or drops in one hand while using the other hand to steady or manipulate the bottle, likely demonstrating how to properly handle or administer the otic suspension.*

FDA Label Image

Figure C (Spl Figure B)

An illustration depicting a person lying on their side, demonstrating the proper position for administering ear drops.*

FDA Label Image

Figure D (Spl Figure C)

An instructional illustration showing an adult hand administering otic suspension or drops into a person's ear canal. The image depicts the correct positioning of the dropper above the ear with drops being released into the ear.*

FDA Label Image

Figure E (Spl Figure E)

An instructional illustration showing how to properly position the ear for administering otic drops. The first image shows a person pulling the outer ear backward; the second image demonstrates pulling the ear up; the third image depicts pulling the ear back (up and slightly backward) to straighten the ear canal before drop administration.*

FDA Label Image

Figure A (Spl Ifu Fig A)

Illustration showing a person washing hands under running water, with hands being rubbed together to demonstrate proper handwashing technique.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.